Service de Neuroradiologie Interventionnelle et Fonctionnelle, Hôpital de la Fondation Ophtalmologique Adolphe de Rothschild, 25-29 Rue Manin 75940 Paris, Cedex 19, France.
Stroke. 2010 Jan;41(1):110-5. doi: 10.1161/STROKEAHA.109.558114. Epub 2009 Dec 3.
Stent-assisted coiling has expanded the treatment of intracranial aneurysms, but the rates of procedure-related neurological complications and the incidence of angiographic aneurysm recurrence of this novel treatment are not yet well known. We present our experience with stent-assisted coiling with special emphasis on procedure-related neurological complications and incidence of angiographic recurrence.
Clinical and angiographic outcomes of 1137 consecutive patients (1325 aneurysms) coiled with and without stent-assisted coiling technique from January 2002 to January 2009 were retrospectively analyzed.
There were 1109 aneurysms (83.5%) treated without and 216 (16.5%) treated with stents (15 of 216; 6.9% balloon-expandable versus 201 of 216; 93.1% self-expandable stents). Stents were delivered after coiling in 55.1% (119 of 216) and before coiling in 44.9% (97 of 216) of the cases. Permanent neurological procedure-related complications occurred in 7.4% (16 of 216) of the procedures with stents versus 3.8% (42 of 1109) in the procedures without stents (logistic regression P=0.644; OR: 1.289; 95% CI: 0.439 to 3.779). Procedure-induced mortality occurred in 4.6% (10 of 216) of the procedures with stents versus 1.2% (13 of 1109) in the procedures without stents (logistic regression P=0.006; OR: 0.116; 95% CI: 0.025 to 0.531). A total of 52.7% (114 of 216) of aneurysms treated with stents have been followed so far versus 69.8% (774 of 1109) of aneurysms treated without stents, disclosing angiographic recurrence in 14.9% (17 of 114) versus 33.5% (259 of 774), respectively (Fisher exact test P<0.0001; OR: 0.3485; 95% CI: 0.2038 to 0.5960).
Stents were associated with a significant decrease of angiographic recurrences, but they were associated with more lethal complications compared with coiling without stents.
支架辅助弹簧圈栓塞术已经扩大了颅内动脉瘤的治疗范围,但是这种新的治疗方法的与手术相关的神经并发症的发生率和血管造影复发率还不是很清楚。我们介绍了我们在支架辅助弹簧圈栓塞术方面的经验,特别强调了与手术相关的神经并发症和血管造影复发的发生率。
回顾性分析了 2002 年 1 月至 2009 年 1 月期间连续 1137 例(1325 个动脉瘤)接受支架辅助弹簧圈栓塞术和未接受支架辅助弹簧圈栓塞术的患者的临床和血管造影结果。
1109 个动脉瘤(83.5%)未接受支架辅助弹簧圈栓塞术,216 个动脉瘤(16.5%)接受了支架辅助弹簧圈栓塞术(15 个,占 216 个;6.9%球囊扩张支架与 201 个,占 216 个;93.1%自膨式支架)。支架在弹簧圈栓塞后放置于 55.1%(119/216)的病例中,在弹簧圈栓塞前放置于 44.9%(97/216)的病例中。支架辅助弹簧圈栓塞术的永久性神经手术相关并发症发生率为 7.4%(16/216),而未支架辅助弹簧圈栓塞术的永久性神经手术相关并发症发生率为 3.8%(42/1109)(逻辑回归 P=0.644;OR:1.289;95%CI:0.439 至 3.779)。支架辅助弹簧圈栓塞术的手术相关死亡率为 4.6%(10/216),而未支架辅助弹簧圈栓塞术的手术相关死亡率为 1.2%(13/1109)(逻辑回归 P=0.006;OR:0.116;95%CI:0.025 至 0.531)。到目前为止,共有 52.7%(114/216)接受支架治疗的动脉瘤得到了随访,而未接受支架治疗的动脉瘤有 69.8%(774/1109)得到了随访,分别有 14.9%(17/114)和 33.5%(259/774)发生血管造影复发(Fisher 精确检验 P<0.0001;OR:0.3485;95%CI:0.2038 至 0.5960)。
支架辅助弹簧圈栓塞术与血管造影复发率的显著降低相关,但与未支架辅助弹簧圈栓塞术相比,支架辅助弹簧圈栓塞术与更致命的并发症相关。